Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer
Go back to Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer| (NASDAQ: NTLA) | Delayed: 12.89 +0.45 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.44 | 52 Week High | $30.40 | |||
| Open | $12.65 | 52 Week Low | $11.86 | |||
| Day High | $13.13 | P/E | N/A | |||
| Day Low | $12.65 | EPS | $0.00 | |||
| Volume | 1,856,564 | |||||

